Results 111 to 120 of about 29,631 (210)

Weekly methotrexate may reduce valproate levels causing relapse of genetic generalized epilepsy

Epilepsy & Behavior Reports, 2021
Ajith Cherian, Sharath Chandra Shetty, K.P. Divya, Harini Pavuluri   +3 more
doaj   +1 more source

Understanding Further the Phenotypic Spectrum of Central Nervous System Inflammatory Demyelinating Disorders Using Unsupervised Clustering

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Central nervous system (CNS) inflammatory demyelinating syndromes, including multiple sclerosis (MS), aquaporin‐4 antibody–positive neuromyelitis optica spectrum disorder (AQP4 + NMOSD), and myelin oligodendrocyte glycoprotein (MOG) antibody–associated disease (MOGAD), occasionally overlap.
Bade Gulec, Elif Everest, Melih Tutuncu, Ugur Bilge, Sabahattin Saip, Ugur Uygunoglu, Aksel Siva   +6 more
wiley   +1 more source

Characteristics associated with first anti-seizure medication prescribed in a cohort of adults with newly diagnosed epilepsy. [PDF]

Seizure
Blank LJ, Morgenstern R, Boockvar K, Mohamed N, Jetté N.   +4 more
europepmc   +1 more source

Discovery of E2730, a novel selective uncompetitive GAT1 inhibitor, as a candidate for anti-seizure medication. [PDF]

Epilepsia Open, 2023
Fukushima K, Higashiyama H, Kazuta Y, Hashimoto K, Watanabe N, Furuya Y, Ito Y, Wu T, Kosasa T, Talos DM, Song Y, Roberts NS, Jensen FE, Hanada T, Ido K.   +14 more
europepmc   +1 more source

Ofatumumab in Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease: A Comparison With Rituximab

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To evaluate the efficacy and safety of ofatumumab in patients with myelin oligodendrocyte glycoprotein antibody–associated disease (MOGAD), and compare it with rituximab. Methods We conducted a single–center, observational study including 22 MOGAD patients treated with ofatumumab and 21 treated with rituximab.
Yuxin Fan, Lei Zhou, Jingzi ZhangBao, Hongmei Tan, Zhouzhou Wang, Chao Quan   +5 more
wiley   +1 more source

Pregnancy, baby, and childhood outcomes from using anti-seizure medication during pregnancy. [PDF]

Commun Med (Lond)
Moore E, Millar M, Merrick R, Mueller T, Stark V, Jarvis L, Kurdi A, Hopkins L, McTaggart S, Vieira R, Bennie M, Wood R.   +11 more
europepmc   +1 more source

Developmental and Behavioral Consequences of Intrauterine Anti-Seizure Medication Exposure. [PDF]

Noro Psikiyatr Ars, 2023
Yaşgüçlükal MA, Savaş M, Acar Z, Başoğlu S, Çokar Ö.   +4 more
europepmc   +1 more source

Influenza Vaccination Responses in Disabled Stroke Patients: A Single‐Center Prospective Observational Study

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective This study aimed to investigate the immunological response to influenza vaccination, the incidence and severity of influenza infection, and the side effects of the vaccination in patients with ischemic stroke. Methods This prospective observational study was conducted between 2023 and 2024 at Ramathibodi Hospital.
Achiraya Pakngao, Sureerat Suwatcharangoon, Pintip Ngamjanyapron, Kobporn Boonnak, Thanitta Suangtamai, Porpon Rotjanapan   +5 more
wiley   +1 more source

Association Between Prophylactic Anti-Seizure Medication and Early Post-Traumatic Seizures: An International Observational Multicenter Study. [PDF]

MedComm (2020)
Ji J, Roa G JD, Chong SL, Wang Q, Gan CS, Ng JPW, Miranda TET, Chamorro FIP, Chan LCN, Abbas Q, Ong JSM, Ardila IJ, Kazzaz YM, Domínguez-Rojas JA, Kurosawa H, Domínguez SBR, Arriola NEG, Watzlawik NZ, Yock-Corrales A, Palomino REL, Aparicio G, Caporal P, Gómez RET, Liu C, Samransamruajkit R, Anantasit N, Turina DM, Flores MF, Lee PC, Pilar-Orive FJ, Dang H, Chor YK, Ming M, Jaramillo-Bustamante JC, González-Dambrauskas S, Lee JH, Qian S.   +36 more
europepmc   +1 more source

Safety and efficacy of rapid withdrawal of anti-seizure medication during long-term video-EEG monitoring. [PDF]

Front Neurol, 2023
Liu J, Chen D, Xu Y, Zhang Y, Liu L.
europepmc   +1 more source